PCSK9缺乏重编程心脏代谢并驱动射血分数保留的心力衰竭
该研究在雄性小鼠中探讨PCSK9缺乏对心脏代谢和功能的影响,发现Pcsk9敲除小鼠出现运动耐力下降和符合HFpEF的超声心动图异常,心脏线粒体呼吸减低、脂质积累增加,且该表型不依赖LDLR,肝脏特异性敲除排除循环PCSK9作用,R46L变异携带者左室质量增加但射血分数相似。
要点
- PCSK9缺乏可导致心脏脂质代谢重编程和线粒体功能下降,驱动HFpEF样表型。
- 该心脏损伤不依赖LDLR,且循环PCSK9不参与,可能由局部产生的PCSK9介导。
- PCSK9 R46L功能缺失变异携带者左室质量增加但射血分数相似,提示临床相关性。
核心结论
- PCSK9缺乏以不依赖LDLR的方式影响心脏脂质代谢,并促进HFpEF的发生。
研究设计与样本
- 研究使用雄性野生型、Pcsk9敲除、肝脏条件性Pcsk9敲除及Pcsk9/Ldlr双敲除小鼠,标准脂肪饮食喂养20周后评估运动耐力、肌肉力量和心脏特征。
主要发现
- Pcsk9敲除小鼠运动耐力下降,超声心动图异常提示HFpEF。
- Pcsk9敲除小鼠心脏线粒体最大偶联和非偶联呼吸减低,心脏代谢显著改变,LDLR和CD36表达增加,脂质积累。
- Pcsk9/Ldlr双敲除小鼠呈现相似表型,排除LDLR对心脏损伤的贡献。
- 肝脏选择性Pcsk9敲除小鼠心脏功能分析排除循环PCSK9参与HFpEF发展,提示局部产生PCSK9的可能作用。
- PCSK9 R46L功能缺失变异携带者左室质量增加,但射血分数与匹配对照相似。
临床怎么用
- 对于PCSK9功能缺失变异携带者,需关注左室质量增加但射血分数保留的心力衰竭风险。
- PCSK9缺乏相关HFpEF不依赖LDLR,提示监测心脏代谢和线粒体功能可能有助于风险评估。
局限性
- 研究主要基于雄性小鼠,性别差异未探讨。
- 人类数据仅为R46L变异携带者的横断面观察,样本量和统计细节未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: PCSK9 is secreted into the circulation, mainly by the liver, and interacts with low-density lipoprotein receptor (LDLR) homologous and non-homologous receptors, including CD36, thus favouring their intracellular degradation. As PCSK9 deficiency increases the expression of lipids and lipoprotein receptors, thus contributing to cellular lipid accumulation, we investigated whether this could affect heart metabolism and function. METHODS AND RESULTS: Wild-type (WT), Pcsk9 KO, Liver conditional Pcsk9 KO and Pcsk9/Ldlr double KO male mice were fed for 20 weeks with a standard fat diet and then exercise resistance, muscle strength, and heart characteristics were evaluated. Pcsk9 KO presented reduced running resistance coupled to echocardiographic abnormalities suggestive of heart failure with preserved ejection fraction (HFpEF). Heart mitochondrial activity, following maximal coupled and uncoupled respiration, was reduced in Pcsk9 KO mice compared to WT mice and was coupled to major changes in cardiac metabolism together with increased expression of LDLR and CD36 and with lipid accumulation. A similar phenotype was observed in Pcsk9/Ldlr DKO, thus excluding a contribution for LDLR to cardiac impairment observed in Pcsk9 KO mice. Heart function profiling of the liver selective Pcsk9 KO model further excluded the involvement of circulating PCSK9 in the development of HFpEF, pointing to a possible role locally produced PCSK9. Concordantly, carriers of the R46L loss-of-function variant for PCSK9 presented increased left ventricular mass but similar ejection fraction compared to matched control subjects. CONCLUSION: PCSK9 deficiency impacts cardiac lipid metabolism in an LDLR independent manner and contributes to the development of HFpEF.
引用
- Da Dalt L, Castiglioni L, Baragetti A, et al. PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction. Eur Heart J. 2021. PMID: 34252181. doi:10.1093/eurheartj/ehab431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。